TENOFOVIR VERSUS ENTECAVIR FOR HEPATOCELLULAR CARCINOMA PREVENTION IN AN INTERNATIONAL CONSORTIUM OF CHRONIC HEPATITIS B

被引：0

作者：

Hsu, Yao-Chun ^{[1
]}

Wong, Grace Lai-Hung ^{[2
,3
]}

Chen, Chien Hung ^{[4
]}

Peng, Cheng-Yuan ^{[5
]}

Yeh, Ming-Lun ^{[6
]}

Cheung, Ka-Shing ^{[7
]}

Toyoda, Hidenori ^{[8
]}

Huang, Chung-Feng ^{[9
]}

Trinh, Huy N. ^{[10
]}

Xie, Qing ^{[11
]}

Enomoto, Masaru ^{[12
]}

Liu, Li ^{[13
]}

Yasuda, Satoshi ^{[8
]}

Tanaka, Yasuhito ^{[14
,15
]}

Kozuka, Ritsuzo ^{[12
]}

Tsai, Pei-Chien ^{[6
]}

Huang, Yen-Tsung ^{[16
]}

Wong, Christopher ^{[17
]}

Huang, Rui ^{[18
]}

Jang, Tyng-Yuan ^{[19
]}

Hoang, Joseph ^{[20
]}

Yang, Hwai-I ^{[21
]}

Li, Jiayi ^{[22
]}

Lee, Dong Hyun ^{[23
]}

Takahashi, Hirokazu ^{[24
]}

Zhang, Jianqing ^{[25
]}

Ogawa, Eiichi ^{[26
]}

Zhao, Changqing ^{[27
]}

Liu, Chenghai ^{[28
]}

Furusyo, Norihiro ^{[26
]}

Eguchi, Yuichiro ^{[29
]}

Wong, Clifford ^{[17
]}

Wu, Chao ^{[18
]}

Kumada, Takashi ^{[30
]}

Yuen, Man-Fung ^{[31
]}

Yu, Ming-Lung ^{[6
]}

Nguyen, Mindie H. ^{[20
]}

机构：

[1] I Shou Univ, Kaohsiung, Taiwan

[2] Chinese Univ Hong Kong, Inst Digest Dis, Dept Med & Therapeut, Hong Kong, Peoples R China

[3] Chinese Univ Hong Kong, State Key Lab Digest Dis, Hong Kong, Peoples R China

[4] Kaohsiung Chang Gung Mem Hosp, Kaohsiung, Taiwan

[5] China Med Univ, Sch Med, Taichung, Taiwan

[6] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[7] Queen Mary Hosp, Med, Hong Kong, Peoples R China

[8] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Gifu, Japan

[9] Kaohsiung Med Univ Hosp, Hepatobiliary Div, Dept Internal Med, Kaohsiung, Taiwan

[10] San Jose Gastroenterol, San Jose, CA USA

[11] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Infect Dis, Shanghai, Peoples R China

[12] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka, Japan

[13] Third Hosp Kumming City, Kunming, Yunnan, Peoples R China

[14] Nagoya City Univ, Grad Sch Med Sci, Dept Virol, Nagoya, Aichi, Japan

[15] Nagoya City Univ, Grad Sch Med Sci, Liver Unit, Nagoya, Aichi, Japan

[16] Acad Sinica, Taipei, Taiwan

[17] Wong Clin, Singapore, Singapore

[18] Nanjing Univ, Sch Med, Nanjing Drum Tower Hosp, Dept Infect Dis,Affiliated Hosp, Nanjing, Jiangsu, Peoples R China

[19] Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan

[20] Stanford Univ, Med Ctr, Div Gastroenterol & Hepatol, Stanford, CA 94305 USA

[21] Acad Sinica, Genom Res Ctr, Taipei, Taiwan

[22] Palo Alto Med Fdn, Mt View Div, Palo Alto, CA USA

[23] Good Gang An Hosp, Busan, South Korea

[24] Saga Univ, Fac Med, Div Endocrinol & Metab, Saga, Japan

[25] Chinese Hosp, Beijing, Peoples R China

[26] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka, Fukuoka, Japan

[27] Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China

[28] Shanghai Univ TCM, Shuguang Hosp, Inst Liver Dis, Shanghai, Peoples R China

[29] Saga Med Sch, Fac Med, Dept Internal Med, Saga, Japan

[30] Ogaki Municipal Hosp, Ogaki, Gifu, Japan

[31] Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China

来源：

HEPATOLOGY | 2019年 / 70卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

459

引用

页码：290A / 291A

页数：2

共 50 条

[21] Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B
Liu, Zhihong
Sun, Jian
Hou, Jinlin
JAMA ONCOLOGY, 2019, 5 (06) : 915 - 915
[22] Tenofovir versus tenofovir plus entecavir for chronic hepatitis B with lamivudine resistance and entecavir resistance
Lee, S.
Ahn, S. H.
Jung, K. S.
Kim, D. Y.
Kim, B. K.
Kim, S. U.
Baatarkhuu, O.
Ku, H. J.
Han, K.
Park, J. Y.
JOURNAL OF VIRAL HEPATITIS, 2017, 24 (02) : 141 - 147
[23] Entecavir vs Tenofovir in Hepatocellular Carcinoma Prevention in Chronic Hepatitis B Infection: A Systematic Review and Meta-Analysis
Cheung, Ka Shing
Mak, Lung Yi
Liu, Sze Hang
Cheng, Ho Ming
Seto, Wai Kay
Yuen, Man Fung
Lai, Ching Lung
CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2020, 11 (10) : e00236
[24] Tenofovir is associated with a better prognosis of hepatocellular carcinoma compared with entecavir in patients with chronic hepatitis B
Um, Hyun Jun
Choi, Jonggi
Lim, Young-Suk
Choi, Won-Mook
JOURNAL OF HEPATOLOGY, 2023, 78 : S1130 - S1131
[25] Incidence and predictors of hepatocellular carcinoma in Caucasian chronic hepatitis B patients receiving entecavir or tenofovir
Papatheodoridis, George V.
Dalekos, George N.
Yurdaydin, Cihan
Buti, Maria
Goulis, John
Arends, Pauline
Sypsa, Vana
Manolakopoulos, Spilios
Mangia, Giampaolo
Gatselis, Nikolaos
Keskin, Onur
Savvidou, Savvoula
Hansen, Bettina E.
Papaioannou, Christos
Galanis, Kostantinos
Idilman, Ramazan
Colombo, Massimo
Esteban, Rafael
Janssen, Harry L. A.
Lampertico, Pietro
JOURNAL OF HEPATOLOGY, 2015, 62 (02) : 363 - 370
[26] Is Tenofovir Superior to Entecavir in Reducing the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B? The Controversy Continues
Lampertico, Pietro
Papatheodoridis, George V.
GASTROENTEROLOGY, 2020, 158 (01) : 42 - 44
[27] Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
Ha, Yeonjung
Chon, Young Eun
Kim, Mi Na
Lee, Joo Ho
Hwang, Seong Gyu
SCIENTIFIC REPORTS, 2020, 10 (01)
[28] Temporal trend and risk determinants of hepatocellular carcinoma in chronic hepatitis B patients on entecavir or tenofovir
Hsu, Yao-Chun
Ho, Hsiu-J.
Lee, Teng-Yu
Huang, Yen-Tsung
Wu, Ming-Shiang
Lin, Jaw-Town
Wu, Chun-Ying
El-Serag, Hashem B.
JOURNAL OF VIRAL HEPATITIS, 2018, 25 (05) : 543 - 551
[29] Hepatocellular carcinoma and death and transplantation in chronic hepatitis B treated with entecavir or tenofovir disoproxil fumarate
Yeonjung Ha
Young Eun Chon
Mi Na Kim
Joo Ho Lee
Seong Gyu Hwang
Scientific Reports, 10
[30] Lower Risk of Hepatocellular Carcinoma With Tenofovir vs Entecavir in Patients With Chronic Hepatitis B Reply
Choi, Jonggi
Ko, Min Jung
Lim, Young-Suk
JAMA ONCOLOGY, 2019, 5 (06) : 916 - 917

← 1 2 3 4 5 →